Japan Lifeline Co., Ltd.(TSE:7575)

Japan Lifeline Co., Ltd. engages in the import, development, production, and distribution of medical devices. It operates through the following divisions: Cardiac Rhythm Management, Electrophysiology and Ablation, Cadiovascular and Vascular Surgery, and Transvascular Intervention. The Cardiac Rhythm Management division provides implantable devices to treat arrhythmias. The Electrophysiology and Ablation division offers disposable catheter devices with electrodes for the diagnosis and treatment of arrhythmias. The Cadiovascular and Vascular Surgery division handles vascular grafts to treat blood vessels. The Transvascular Intervention division deals with devices for intravascular treatment of cardiac infarction, arterial occlusions of the lower extremities, and congenital cardiac diseases. The company was founded by Keisuke Suzuki and Takeshi Masumoto on February 6, 1981 and is headquartered in Tokyo, Japan.